S100A7 (psoriasin) influences immune response genes in human breast cancer

Experimental Cell Research

Volumn 313, Issue 14, 2007, Pages 3016-3025

  Mandal, Soma ^a,b   Curtis, Linda ^a   Pind, Molly ^a,b   Murphy, Leigh C ^a,b   Watson, Peter H ^a,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

CARRIE; CD74; GenMAPP; MDA MB 231; MDA MB 468; MHC class II; Microarray; S100A7; SAGE; TMA

Indexed keywords

ESTROGEN RECEPTOR ALPHA; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; PSORIASIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

ANTIGEN PRESENTATION; ARTICLE; BREAST CANCER; CD74 GENE; CONTROLLED STUDY; DNA MICROARRAY; EARLY CANCER; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SERIAL ANALYSIS OF GENE EXPRESSION; TISSUE MICROARRAY; UNINDEXED SEQUENCE;

EID: 34547145921     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2007.03.020     Document Type: Article

References (39)

1. Madsen P., Rasmussen H.H., Leffers H., Honore B., Dejgaard K., Olsen E., Kiil J., Walbum E., Andersen A.H., and Basse B. Molecular cloning, occurrence, and expression of a novel partially secreted protein "S100A7" that is highly up-regulated in psoriatic skin. J. Invest. Dermatol. 97 (1991) 701-712
2. Alowami S., Qing G., Emberley E., Snell L., and Watson P.H. S100A7 (S100A7) expression is altered during skin tumorigenesis. BMC Dermatol. 3 (2003) 1
3. Celis J.E., Rasmussen H.H., Vorum H., Madsen P., Honore B., Wolf H., and Orntoft T.F. Bladder squamous cell carcinomas express S100A7 and externalize it to the urine. J. Urol. 155 (1996) 2105-2112
4. Emberley E.D., Murphy L.C., and Watson P.H. S100 proteins and their influence on pro-survival pathways in cancer. Biochem. Cell. Biol. 82 (2004) 508-515
5. Enerback C., Porter D.A., Seth P., Sgroi D., Gaudet J., Weremowicz S., Morton C.C., Schnitt S., Pitts R.L., Stampl J., Barnhart K., and Polyak K. S100A7 expression in mammary epithelial cells in vitro and in vivo. Cancer Res. 62 (2002) 43-47
6. Emberley E.D., Niu Y., Leygue E., Tomes L., Gietz R.D., Murphy L.C., and Watson P.H. S100A7 interacts with Jab1 and influences breast cancer progression. Cancer Res. 63 (2003) 1954-1961
7. Emberley E.D., Niu Y., Curtis L., Troup S., Mandal S.K., Myers J.N., Gibson S.B., Murphy L.C., and Watson P.H. The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer. Cancer Res. 65 (2005) 5696-5702
8. Leygue E., Snell L., Hiller T., Dotzlaw H., Hole K., Murphy L.C., and Watson P.H. Differential expression of S100A7 messenger RNA between in situ and invasive human breast carcinoma. Cancer Res. 56 (1996) 4606-4609
9. Watson P.H., Leygue E.R., and Murphy L.C. S100A7 (S100A7). Int. J. Biochem. Cell Biol. 30 (1998) 567-571
10. Moog-Lutz C., Bouillet P., Regnier C.H., Tomasetto C., Mattei M.G., Chenard M.P., Anglard P., Rio M.C., and Basset P. Comparative expression of the S100A7 (S100A7) and S100C genes in breast carcinoma and co-localization to human chromosome 1q21-q22. Int. J. Cancer 63 (1995) 297-303
11. Emberley E.D., Alowami S., Snell L., Murphy L.C., and Watson P.H. S100A7 (S100A7) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast. Breast Cancer Res. 6 (2004) R308-R315
12. Krop I., Marz A., Carlsson H., Li X., Bloushtain-Qimron N., Hu M., Gelman R., Sabel M.S., Schnitt S., Ramaswamy S., Kleer C.G., Enerback C., and Polyak K. A putative role for S100A7 in breast tumor progression. Cancer Res. 65 (2005) 11326-11334
13. Al-Haddad S., Zhang Z., Leygue E., Snell L., Huang A., Niu Y., Hiller-Hitchcock T., Hole K., Murphy L.C., and Watson P.H. S100A7 (S100A7) expression and invasive breast cancer. Am. J. Pathol. 155 (1999) 2057-2066
14. Velculescu V.E., Zhang L., Vogelstein B., and Kinzler K.W. Serial analysis of gene expression. Science 270 (1995) 484-487
15. Romualdi C., Bortoluzzi S., D'Alessi F., and Danieli G.A. IDEG6: a web tool for detection of differentially expressed genes in multiple tag sampling experiments. Physiol. Genomics 12 (2003) 159-162
16. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(- Delta Delta C(T)) Method. Methods 25 (2001) 402-408
17. Tomes L., Emberley E., Niu Y., Troup S., Pastorek J., Strange K., Harris A., and Watson P.H. Necrosis and hypoxia in invasive breast carcinoma. Breast Cancer Res. Treat. 81 (2003) 61-69
18. Haverty P.M., Hansen U., and Weng Z. Computational inference of transcriptional regulatory networks from expression profiling and transcription factor binding site identification. Nucleic Acids Res. 32 (2004) 179-188
19. Doniger S.W., Salomonis N., Dahlquist K.D., Vranizan K., Lawlor S.C., and Conklin B.R. MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol. 4 (2003) R7
20. Porter D., Lahti-Domenici J., Keshaviah A., Bae Y.K., Argani P., Marks J., Richardson A., Cooper A., Strausberg R., Riggins G.J., Schnitt S., Gabrielson E., Gelman R., and Polyak K. Molecular markers in ductal carcinoma in situ of the breast. Mol. Cancer Res. 1 (2003) 362-375
21. Schroder J.M., and Harder J. Antimicrobial skin peptides and proteins. Cell. Mol. Life Sci. 63 (2006) 469-486
22. Meyer-Siegler K.L., Leifheit E.C., and Vera P.L. Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cells. BMC Cancer 4 (2004) 34
23. Starlets D., Gore Y., Binsky I., Haran M., Harpaz N., Shvidel L., Becker-Herman S., Berrebi A., and Shachar I. Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival. Blood 107 (2006) 4807-4816
24. Leng L., Metz C.N., Fang Y., Xu J., Donnelly S., Baugh J., Delohery T., Chen Y., Mitchell R.A., and Bucala R. MIF signal transduction initiated by binding to CD74. J. Exp. Med. 197 (2003) 1467-1476
25. Kleemann R., Hausser A., Geiger G., Mischke R., Burger-Kentischer A., Flieger O., Johannes F.J., Roger T., Calandra T., Kapurniotu A., Grell M., Finkelmeier D., Brunner H., and Bernhagen J. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408 (2000) 211-216
26. Ishigami S., Natsugoe S., Tokuda K., Nakajo A., Iwashige H., Aridome K., Hokita S., and Aikou T. Invariant chain expression in gastric cancer. Cancer Lett. 168 (2001) 87-91
27. Young A.N., Amin M.B., Moreno C.S., Lim S.D., Cohen C., Petros J.A., Marshall F.F., and Neish A.S. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am. J. Pathol. 158 (2001) 1639-1651
28. Sheridan C., Sadaria M., Bhat-Nakshatri P., Goulet Jr. R., Edenberg H.J., McCarthy B.P., Chang C.H., Srour E.F., and Nakshatri H. Negative regulation of MHC class II gene expression by CXCR4. Exp. Hematol. 34 (2006) 1085-1092
29. Jinquan T., Vorum H., Larsen C.G., Madsen P., Rasmussen H.H., Gesser B., Etzerodt M., Honore B., Celis J.E., and Thestrup-Pedersen K. S100A7: a novel chemotactic protein. J. Invest. Dermatol. 107 (1996) 5-10
30. Webb M., Emberley E.D., Lizardo M., Alowami S., Qing G., Alfia'ar A., Snell-Curtis L.J., Niu Y., Civetta A., Myal Y., Shiu R., Murphy L.C., and Watson P.H. Expression analysis of the mouse S100A7/S100A7 gene in skin inflammation and mammary tumorigenesis. BMC Cancer 5 (2005) 17
31. Alowami S., Qing G., Emberley E., Snell L., and Watson P.H. S100A7 (S100A7) expression is altered during skin tumorigenesis. BMC Dermatol. 3 (2003) 1
32. Claret F.X., Hibi M., Dhut S., Toda T., and Karin M. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 383 (1996) 453-457
33. Bae M.K., Ahn M.Y., Jeong J.W., Bae M.H., Lee Y.M., Bae S.K., Park J.W., Kim K.R., and Kim K.W. Jab1 interacts directly with HIF-1alpha and regulates its stability. J. Biol. Chem. 277 (2002) 9-12
34. Dechend R., Hirano F., Lehmann K., Heissmeyer V., Ansieau S., Wulczyn F.G., Scheidereit C., and Leutz A. The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators. Oncogene 18 (1999) 3316-3323
35. Carlsson H., Yhr M., Petersson S., Collins N., Polyak K., and Enerback C. S100A7 (S100A7) and Calgranulin-B (S100A9) induction is dependent on reactive oxygen species and is downregulated by Bcl-2 and antioxidants. Cancer Biol. Ther. 4 (2005)
36. van K.M., de G.K., van V.H., Aten J., and Snoek M. Genotype versus phenotype: conflicting results in mapping a lung tumor susceptibility locus to the G7c recombination interval in the mouse MHC class III region. Immunogenetics 53 (2001) 656-661
37. Shimo T., Kubota S., Kondo S., Nakanishi T., Sasaki A., Mese H., Matsumura T., and Takigawa M. Connective tissue growth factor as a major angiogenic agent that is induced by hypoxia in a human breast cancer cell line. Cancer Lett. 174 (2001) 57-64
38. Higgins D.F., Biju M.P., Akai Y., Wutz A., Johnson R.S., and Haase V.H. Hypoxic induction of Ctgf is directly mediated by Hif-1. Am. J. Physiol., Renal Physiol. 287 (2004) F1223-F1232
39. Moritani N.H., Kubota S., Eguchi T., Fukunaga T., Yamashiro T., Takano-Yamamoto T., Tahara H., Ohyama K., Sugahara T., and Takigawa M. Interaction of AP-1 and the ctgf gene: a possible driver of chondrocyte hypertrophy in growth cartilage. J. Bone Miner. Metab. 21 (2003) 205-210